Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-20
DOI
10.3389/fphar.2018.00196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting A2 adenosine receptors in cancer
- (2017) David Allard et al. IMMUNOLOGY AND CELL BIOLOGY
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells
- (2017) Giulia Mesiano et al. MOLECULAR MEDICINE
- Industry 'road tests' new wave of immune checkpoints
- (2017) Ken Garber NATURE BIOTECHNOLOGY
- A Purinergic Trail for Metastases
- (2017) Davide Ferrari et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
- (2017) Federica Costa et al. Oncotarget
- Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
- (2017) Antonella Chillemi et al. Frontiers in Immunology
- A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer
- (2016) Stephen M Hatfield et al. CURRENT OPINION IN PHARMACOLOGY
- Immunosuppressive activities of adenosine in cancer
- (2016) Bertrand Allard et al. CURRENT OPINION IN PHARMACOLOGY
- Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
- (2016) Larysa Sanchez et al. Journal of Hematology & Oncology
- Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
- (2016) Alberto L Horenstein et al. MOLECULAR MEDICINE
- Inseparable tandem: evolution chooses ATP and Ca2+to control life, death and cellular signalling
- (2016) Helmut Plattner et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment
- (2016) Luca Antonioli et al. OncoImmunology
- Purinergic signaling in schistosomal infection
- (2016) Claudia Lucia Martins Silva Biomedical Journal
- Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives
- (2015) Lidia Giraudo et al. Immunotherapy
- Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer
- (2015) Severin Schmid et al. LUNG CANCER
- A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
- (2015) Fabio Morandi et al. Oncotarget
- NAD+-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
- (2015) Alberto Horenstein et al. Cells
- Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
- (2014) Valeria Quarona et al. Annals of the New York Academy of Sciences
- Direct involvement of CD56 in cytokine-induced killer–mediated lysis of CD56+ hematopoietic target cells
- (2014) Rut Valgardsdottir et al. EXPERIMENTAL HEMATOLOGY
- Purinergic signalling and immune cells
- (2014) Geoffrey Burnstock et al. Purinergic Signalling
- Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
- (2014) M. V. Sitkovsky et al. Cancer Immunology Research
- Th17 Cells in Cancer: The Ultimate Identity Crisis
- (2014) Stefanie R. Bailey et al. Frontiers in Immunology
- A2Ablockade enhances anti-metastatic immune responses
- (2014) Paul A Beavis et al. OncoImmunology
- Co-blockade of immune checkpoints and adenosine A2Areceptor suppresses metastasis
- (2014) Arabella Young et al. OncoImmunology
- Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
- (2013) D. Sangiolo et al. CANCER RESEARCH
- Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
- (2013) L. Gammaitoni et al. CLINICAL CANCER RESEARCH
- Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms
- (2013) M. Introna et al. IMMUNOLOGY LETTERS
- Cytokine-induced killer cells promote antitumor immunity
- (2013) Jingting Jiang et al. Journal of Translational Medicine
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Adenosine receptors as drug targets — what are the challenges?
- (2013) Jiang-Fan Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models
- (2013) Shujing Shi et al. PLoS One
- Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
- (2013) C. J. Desmet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity
- (2013) Hing C Wong et al. OncoImmunology
- A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
- (2013) Alberto L Horenstein et al. OncoImmunology
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Anti-Inflammatory and Immunosuppressive Effects of the A2AAdenosine Receptor
- (2011) Gillian R. Milne et al. TheScientificWorldJOURNAL
- Signalling and pharmacological properties of the P2Y14 receptor
- (2010) T. K. Harden et al. Acta Physiologica
- Intrarenal Purinergic Signaling in the Control of Renal Tubular Transport
- (2010) Helle A. Praetorius et al. Annual Review of Physiology
- Cytokine-Induced NK-Like T Cells: From Bench to Bedside
- (2010) Yeh Ching Linn et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Release of Adenosine and ATP During Ischemia and Epilepsy
- (2009) Nicholas Dale et al. Current Neuropharmacology
- Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes
- (2009) Marta Franceschetti et al. EXPERIMENTAL HEMATOLOGY
- Signaling at Purinergic P2X Receptors
- (2008) Annmarie Surprenant et al. Annual Review of Physiology
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
- (2008) Gennady G. Yegutkin BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
- (2008) Fabio Malavasi et al. PHYSIOLOGICAL REVIEWS
- Adenosine in the central nervous system: release mechanisms and extracellular concentrations
- (2003) Serena Latini et al. JOURNAL OF NEUROCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now